Clinical Trials on Relapse in United Kingdom
Total 960 results
-
BeiGeneRecruitingMantle Cell Lymphoma | Relapsed Mantle Cell Lymphoma | Refractory Mantle Cell Lymphoma (MCL)United States, China, Israel, Belgium, Poland, Spain, Turkey, Brazil, Italy, Canada, United Kingdom, France, Germany, Argentina, Puerto Rico
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers Squibb; MultiVir, Inc.TerminatedSmall Cell Lung Cancer | Lung Cancer | Relapsed Small Cell Lung CancerUnited States
-
AstraZenecaMyriad Genetic Laboratories, Inc.WithdrawnPlatinum Sensitive Relapsed Ovarian CancerUnited States, Korea, Republic of, Peru, United Kingdom, Philippines
-
University of Texas at AustinRecruitingPelvic Organ Prolapse | Stress Urinary Incontinence | Urinary Retention | Catheter Related ComplicationUnited States
-
University of New MexicoUniversity of Texas at Austin; Albany Medical CollegeTerminatedUrinary Incontinence | Pelvic Organ Prolapse | Fecal Incontinence | Sexual Function DisturbancesUnited States
-
University of Texas Southwestern Medical CenterWithdrawnProlapse | Leiomyoma | IncontinenceUnited States
-
University of PennsylvaniaGenentech, Inc.Recruiting
-
University of Maryland, BaltimoreActive, not recruitingRelapsed/Refractory Multiple MyelomaUnited States
-
Kite, A Gilead CompanyRecruitingRelapsed/Refractory Large B-cell LymphomaUnited States, Australia, Canada
-
Alfred Chung, MDMerck Sharp & Dohme LLCTerminatedMultiple Myeloma | Refractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma | Multiple Myeloma in Relapse | Multiple Myeloma, RefractoryUnited States
-
Novartis PharmaceuticalsTerminatedRelapsed or Refractory Chronic Lymphocytic Leukemia (CLL)Spain, United States
-
Bristol-Myers SquibbRecruitingRelapsed/Refractory Non-Hodgkin LymphomaUnited States, Spain, France, Netherlands, Switzerland
-
Cleave Therapeutics, Inc.CompletedMyelodysplastic Syndromes | Acute Myeloid Leukemia, in RelapseUnited States, Australia
-
Washington University School of MedicineNational Cancer Institute (NCI); MacroGenicsRecruitingRelapsed Acute Myeloid LeukemiaUnited States
-
University of IowaCompleted
-
Cullinan Therapeutics Inc.Active, not recruitingA Study of CLN-978 in Patients With Relapsed or Refractory (R/R) B Cell Non-Hodgkin Lymphoma (B-NHL)NHL | NHL, Relapsed, AdultUnited States
-
Texas A&M UniversityMedical University of South Carolina; National Institute on Alcohol Abuse and...RecruitingPosttraumatic Stress Disorder | Alcohol Use DisorderUnited States
-
Regeneron PharmaceuticalsRecruitingRelapsed/Refractory Aggressive B-Cell LymphomaUnited States, Germany, Spain
-
Telios Pharma, Inc.Active, not recruitingChronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | Relapsed/Refractory B Cell Malignancies | Mantle Cell Lymphoma and Diffuse Large B Cell Lymphoma | Treatment-Naive B Cell MalignanciesUnited States, Poland, Ukraine, Hungary, Italy, Russian Federation, United Kingdom
-
Thomas Jefferson UniversityRecruitingRelapse Remitting Multiple SclerosisUnited States
-
ProgenaBiomeRecruitingCrohn Disease | Crohn Colitis | Crohn's Ileocolitis | Crohn's Gastritis | Crohn's Jejunitis | Crohn's Duodenitis | Crohn's Esophagitis | Crohn's | Crohn Disease of Ileum | Crohn Ileitis | Crohn's Disease Relapse | Crohns Disease Aggravated | Crohn Disease in Remission | Crohn's Disease of PylorusUnited States
-
PharmaMarCompletedRelapsed/Refractory Multiple MyelomaUnited States, Australia, Austria, Belgium, Czechia, France, Germany, Greece, Ireland, Italy, Korea, Republic of, Netherlands, New Zealand, Poland, Portugal, Puerto Rico, Spain, Taiwan, United Kingdom
-
Jazz PharmaceuticalsRecruitingEwing Sarcoma | Refractory Ewing Sarcoma | Relapsed Ewing SarcomaUnited States, Canada
-
Rapa Therapeutics LLCMedical College of WisconsinRecruitingRelapsed, Refractory Multiple MyelomaUnited States
-
University of PennsylvaniaCompletedPatients With B Cell ALL, Relapsed or Refractory, With no Available Curative Treatment OptionsUnited States
-
Dana-Farber Cancer InstituteLeadiant Biosciences, Inc.TerminatedT-Cell Lymphoma | Relapsed T-Cell Lymphoma | Refractory T-Cell LymphomaUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Pfizer; The Leukemia and Lymphoma SocietyTerminatedRefractory Acute Leukemia | Relapsed Acute Leukemia | High-Risk MyelodysplasiaUnited States
-
Kathleen DorritieBristol-Myers SquibbRecruitingRelapsed and Refractory Multiple MyelomaUnited States
-
Barbara Ann Karmanos Cancer InstituteWithdrawnRelapsed Diffuse Large B-cell LymphomaUnited States
-
Weill Medical College of Cornell UniversityJazz PharmaceuticalsCompletedMyelodysplastic Syndromes | Leukemia, Myeloid, Acute | Leukemia, Relapsed Adult Acute Myeloid | Myelodysplastic Syndromes, Previously TreatedUnited States
-
Adriana RossiNot yet recruitingRelapsed and/or Refractory Multiple MyelomaUnited States
-
Massachusetts General HospitalSanofi; GlaxoSmithKlineNot yet recruitingMultiple Myeloma | Refractory Multiple Myeloma | Relapsed CancerUnited States
-
Carl Ola Landgren, MD, PhDBristol-Myers SquibbRecruitingRefractory Multiple Myeloma | Relapsed Multiple MyelomaUnited States
-
Lazaros LekakisGenentech, Inc.RecruitingRefractory Non-Hodgkin Lymphoma | Relapsed Non Hodgkin Lymphoma | Aggressive Non-Hodgkin LymphomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteJazz PharmaceuticalsCompletedAcute Lymphoblastic Leukemia | Refractory Acute Lymphoblastic Leukemia | Relapsed Acute Lymphoblastic Leukemia | Lymphoid LeukemiaUnited States
-
NYU Langone HealthCelgene CorporationTerminatedRelapsed or Refractory Multiple MyelomaUnited States
-
Kronos BioTerminatedAcute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Relapsed Acute Myeloid LeukemiaUnited States, Spain
-
Fortis Therapeutics, Inc.CompletedMultiple Myeloma | Multiple Myeloma in Relapse | Multiple Myeloma With Failed RemissionUnited States
-
Dana-Farber Cancer InstitutePatient-Centered Outcomes Research InstituteActive, not recruitingRelapsed NeuroblastomaUnited States
-
Allogene TherapeuticsActive, not recruitingRelapsed/Refractory Multiple MyelomaUnited States
-
Marker Therapeutics, Inc.RecruitingNon Hodgkin Lymphoma | Non-Hodgkin Lymphoma, Adult | Non-Hodgkin Lymphoma, Refractory | Non-Hodgkin Lymphoma, RelapsedUnited States
-
University of California, San DiegoTakeda; Celgene; Janssen, LPActive, not recruitingRelapsed/Refractory Multiple MyelomaUnited States
-
Medical College of WisconsinChildren's Hospital and Health System Foundation, WisconsinRecruitingAcute Lymphoblastic Leukemia | Acute Lymphoblastic Leukemia, Pediatric | Acute Lymphoblastic Leukemia, in Relapse | Acute Lymphoblastic Leukemia Recurrent | Acute Lymphoblastic Leukemia With Failed Remission | Acute Lymphoblastic Leukemia Not Having Achieved RemissionUnited States
-
Altor BioScienceNational Cancer Institute (NCI)TerminatedRelapsed or Refractory Multiple MyelomaUnited States
-
Washington University School of MedicineGenzyme, a Sanofi CompanyCompletedRelapsed Or Refractory Multiple MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterDana-Farber Cancer Institute; Stanford UniversityActive, not recruitingLymphoma | Relapsed/Refractory T-cell LymphomasUnited States
-
Children's Hospital of PhiladelphiaWithdrawnHemophagocytic LymphohistiocytosisUnited States
-
Allogene TherapeuticsRecruitingRelapsed/Refractory Large B Cell LymphomaBelgium, United States, Austria
-
Millennium Pharmaceuticals, Inc.CompletedRelapsed Follicular LymphomaUnited States, Puerto Rico
-
AmgenTerminatedMyelodysplastic Syndrome | Relapsed/Refractory AML | Minimal Residual Disease Positive AMLUnited States, Canada, Germany, Netherlands